Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, announced that Medidata Health Record Connect and Medidata Rave Companion, both integral components of the Medidata Data Experience, will be available to a select set of National Cancer Institute (NCI) Lead Protocol Organizations (LPO). These solutions automatically enable patient data from electronic health records (EHR) systems to be elevated into the Medidata Platform, reducing administrative burdens, providing medical and clinical new levels of insights, and giving sites more time to focus on patient care.
"For years, the industry has struggled with a scalable way to use EHR in clinical studies. With Health Record Connect and Companion, we're finally solving that challenge for NCI LPOs,” said Wayne Walker, senior vice president, Data Experience, Medidata. “By reducing duplicative tasks for research sites, we're not only making it easier for patients to participate in trials but also accelerating timelines and improving overall data quality. This technology is a game-changer for bringing therapies to market more reliably and enhancing the experience for both researchers and patients."
Health Record Connect and Rave Companion simplify access to a clinical trial site’s EHR data and enable automated and accurate completion of clinical trial site data entry tasks. These solutions are seamlessly integrated with the entire Data Experience, supporting both site and patient data collection and empowering NCI LPOs with the potential to input data up to 90% faster.
Medidata has supported the NCI Cancer Therapy Evaluation Program (CTEP) study portfolio with tools across the Medidata Platform for the past 17 years, strengthening the collaboration and reinforcing NCI’s ability to manage clinical operations effectively.
To view the original press release, please click here.
